- Home
- TOPP vs FEMY Comparison
TOPP vs FEMY Comparison
Compare TOPP & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- FEMY
- Stock Information
- Founded
- TOPP 2014
- FEMY 2004
- Country
- TOPP United States
- FEMY United States
- Employees
- TOPP N/A
- FEMY N/A
- Industry
- TOPP
- FEMY Medical/Dental Instruments
- Sector
- TOPP
- FEMY Health Care
- Exchange
- TOPP NYSE
- FEMY Nasdaq
- Market Cap
- TOPP 26.6M
- FEMY 31.9M
- IPO Year
- TOPP 2025
- FEMY 2021
- Fundamental
- Price
- TOPP $1.73
- FEMY $0.92
- Analyst Decision
- TOPP
- FEMY Strong Buy
- Analyst Count
- TOPP 0
- FEMY 3
- Target Price
- TOPP N/A
- FEMY $8.67
- AVG Volume (30 Days)
- TOPP 7.9K
- FEMY 369.9K
- Earning Date
- TOPP 08-11-2025
- FEMY 08-07-2025
- Dividend Yield
- TOPP N/A
- FEMY N/A
- EPS Growth
- TOPP N/A
- FEMY N/A
- EPS
- TOPP N/A
- FEMY N/A
- Revenue
- TOPP $16,117,227.00
- FEMY $1,699,232.00
- Revenue This Year
- TOPP N/A
- FEMY $231.84
- Revenue Next Year
- TOPP N/A
- FEMY $245.28
- P/E Ratio
- TOPP N/A
- FEMY N/A
- Revenue Growth
- TOPP 0.44
- FEMY 61.97
- 52 Week Low
- TOPP $0.97
- FEMY $0.69
- 52 Week High
- TOPP $4.50
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- FEMY 46.80
- Support Level
- TOPP N/A
- FEMY $0.91
- Resistance Level
- TOPP N/A
- FEMY $0.99
- Average True Range (ATR)
- TOPP 0.00
- FEMY 0.06
- MACD
- TOPP 0.00
- FEMY 0.01
- Stochastic Oscillator
- TOPP 0.00
- FEMY 28.00
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.